Medline has expanded its respiratory care offerings with the introduction of the new Hudson RCI TurboMist small-volume nebuliser.

The new device is designed to deliver medication treatments rapidly, with the capability to complete the process in as little as three minutes.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The TurboMist nebuliser is engineered to dispense 2.5 times more medication per minute compared to standard nebulisers, slashing treatment times by nearly 70%.

This efficiency not only accelerates care delivery but also enhances cost-effectiveness, Medline said.

Furthermore, the nebuliser offers better medication deposition for quicker patient relief, improved patient compliance due to reduced treatment duration, and greater comfort and efficacy with a swivel mouthpiece that minimises mask usage.

It is suitable for patients aged five years and older in both hospital and homecare settings.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medline clinical specialist and registered respiratory therapist James Donegan said: “Respiratory therapists are constantly adapting and innovating to solve challenges to better care for patients, and we strive to innovate right beside them to strengthen the respiratory therapy sector. Over the years, we have developed robust solutions to meet every respiratory need, from hospital to home.

“We believe that our newest solution, TurboMist, will fulfil a need in the market to drive efficiencies with shorter medication delivery times and an enhanced patient experience.”

Earlier this year, Medline launched OptiView transparent dressing with HydroCore Technology to enable easy assessment of at-risk skin and monitoring skin breakdown.

The dressing’s design allows caregivers to inspect and monitor the skin quickly and easily without the need to remove the dressing.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact